Status
Conditions
Treatments
About
Thrombotic biomarkers and angiographic characteristics were compared among the de novo patients of central serous chorioretinopathy (CSC), polypoidal choroidal vasculopathy (PCV) and the control.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
CSC
PCV
Control
Exclusion criteria
100 participants in 3 patient groups
Loading...
Central trial contact
Se Woong Kang, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal